The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients

A. Feit, M. Cohen, L. Dimino, N. El-Sherif, R. Holtzman, C. V S Ram, D. Gaffeny, J. A. Heller, Norman M Kaplan

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The antihypertensive and haemodynamic effects of labetalol were compared with those of prazosin both at rest and during bicycle exercise in 38 moderate to moderately severe hypertensive patients (supine DBP 95 to 119 mmHg when untreated). Following a two week open placebo phase to establish baseline exercise performance, patients were randomly and double-blindedly assigned to receive labetalol or prazosin. Drug dose was titrated from 100 to 400 mg labetalol twice daily, or from one to 10 mg prazosin twice daily at weekly intervals until BP was controlled (supine DBP ≤ 90 mmHg with at least a 10 mmHg decrease from baseline). Eighteen labetalol and twenty prazosin patients achieved BP control and were subsequently re-exercised to fatigue on a bicycle ergometer. The mean changes from baseline for heart rate and rate pressure product (heart rate x SBP) were reduced only in the labetalol group; the difference between the labetalol and prazosin groups was significant (P < 0.01) both at rest and during exercise. This haemodynamic profile of labetalol may be important in selecting a vasodilating antihypertensive for patients with concomitant ischaemic heart disease.

Original languageEnglish (US)
Pages (from-to)39-43
Number of pages5
JournalJournal of Human Hypertension
Issue number1
StatePublished - Jan 1 1991

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients'. Together they form a unique fingerprint.

Cite this